CP-724,714

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CP-724,714, covering 2010-08-27 to 2010-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer [Phase 2]